Fall Clinical Dermatology Conference

Raj Chovatiya, MD, PhD, assistant professor of dermatology and Medical Director, Center for Eczema and Itch and Medical Director, Clinical Trials Unit at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, shares highlights from his upcoming presentations at Fall Clinical in Las Vegas, Nevada, October 20-23, 2022.

Lisa Swanson, MD, FAAD, a pediatric dermatologist in Boise, Idaho, presents all that is new and hot in pediatric dermatology at the 2022 Fall Clinical Conference in Las Vegas Nevada, October 20-23.

Christopher Bunick, MD, shares highlights of his session from the 2022 Fall Clinical conference in Las Vegas, Nevada, October 20-23.

The 2022 Fall Clinical Dermatology Conference begins today in Las Vegas, Nevada, and continues through October 23rd.

Skin sensitivity will be a factor in vehicles for new treatments.

Mark G. Lebwohl, MD, presents on what dermatologists need to know about the newest psoriasis studies during the Fall Clinical Dermatology Conference.

FDA approval of ruxolitinib (Opzelura, Incyte) adds the first new topical anti-inflammatory to the atopic dermatitis (AD) armamentarium in 50 years, but boxed warnings raise questions.

Botulinum type A injections are widely used across the dermatology and aesthetic medicine specialties. At the Fall Clinical Dermatology Conference 2021, Mark S Nestor, MD, PhD, highlights how to optimize the neurotoxin to improve patient care.

Racial disparities in antibiotic prescription also influence treatment decisions.

People are born with sterile skin and then gain microbiota throughout their life. Lawrence J. Green, MD, FAAD, explains how this affects the skin barrier and ultimately plays a role in atopic dermatitis at the 2021 Fall Clinical Dermatology Conference.

In a video onsite at Fall Clinical Dermatology Conference, Darrell S. Rigel, MD, MS, highlights, in his own words, the potential of GEP as an adjunct to biopsy in melanoma detection.

Lawrence Eichenfield, MD, provides the newest updates in pediatric patient care, with a special update on COVID-19 skin symptoms in children.

LEO Pharma releases the 16-week data regarding tralokinumab (Adtralza; LEO Pharma) as a treatment for adolescent patients aged 12 to 17 years.

Cantharidin 0.7% could be an emerging standard for molluscum treatment.

How can GEP be applied to melanoma diagnosis and treatment? Darrel Rigel, MD, MS, answers these questions and dives into the data at Fall Clinical Dermatology Conference 2021.

Neal Bhatia, MD, explores steroid alternatives in his presentation at the Fall Clinical Dermatology Conference.

Dermatology Times talked with several experts over the course of the Fall Clinical Dermatology meeting to glean practical insights from their presentations.

JAK inhibitors have shown efficacy across several conditions due to the number and role of cytokines in the pathogenesis of these conditions, one expert says.

Dr. Susan Weinkle offers tips to minimize discomfort, which plays a large role in the patient’s perception of outcome.

Dr. Scott Dinehart discusses two newer methods for attacking squamous cell carcinoma, which he says are critical to know.

The shift from antihistamines to newer drugs for treating pruritus is rapidly accelerating. Gil Yosipovitch, M.D. shares the treatments you should know in his presentation at the Fall Clinical Dermatology Conference in Las Vegas.

For many years, genetic expression profiling has helped physicians predict which patients are at the highest risk of having their melanoma metastasize. Now, this same approach could aid in treating squamous cell carcinoma of the skin.

Hilary Baldwin, M.D., discusses the nuances of adult female acne and its treatments in her presentation at the Fall Clinical Dermatology Conference in Las Vegas.

Researcher experiments with reformulating psoriasis topical as a lotion instead of cream, which performed well with patients.

Cosmetic products with prebiotics, probiotics and postbiotics may be beneficial in treating eczema, a physician reported at the Fall Clinical Dermatology Conference held earlier this month in Las Vegas.

Patients are increasingly seeking to have benign lesions removed and today, there are a number of treatment options available to safely and effectively remove unwanted lesions. Suneel Chilukuri, M.D., reviewed these options during a presentation at the Fall Clinical Dermatology Conference held this week in Las Vegas.

Qbrexza was approved earlier this year for primary axillary hyperhidrosis. And, now, other treatments are under study. In his presentation at this week’s Fall Clinical Dermatology Conference in Las Vegas, Dr. David Pariser summarizes the latest research.

In a presentation at the Fall Clinical Dermatology Conference held on Saturday in Las Vegas, Diane Berson, M.D., outlined trends and new ingredients in oral and topical cosmeceuticals.

Photodynamic therapy (PDT) has multiple uses, but billing can be complicated. In this article, we outline its uses and billing codes.

At the Fall Clinical Dermatology Conference in Las Vegas, one practical talk with a lot of takeaways was a workshop on two types of diagnostic tests for mole genomics.